The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-15
DOI
10.1186/s13045-021-01159-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation
- (2021) Huidong Guo et al. Cellular & Molecular Immunology
- Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA
- (2021) Yingling Zu et al. Scientific Reports
- Disease Risk Comorbidity Index for Patients Receiving Haploidentical Allogeneic Hematopoietic Transplantation
- (2021) Xiao-Dong Mo et al. Engineering
- Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysis
- (2021) Linhui Hu et al. ANNALS OF HEMATOLOGY
- Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years
- (2021) Jakob R. Passweg et al. BONE MARROW TRANSPLANTATION
- The Chinese HCT survey: a non-manipulated haploidentical transplantation procedure makes a novel contribution to data sharing within the regional and global transplant registries and to worldwide knowledge
- (2021) Dietger Niederwieser BONE MARROW TRANSPLANTATION
- Haploidentical Stem Cell Transplantation With a Novel Conditioning Regimen in Older Patients: A Prospective Single-Arm Phase 2 Study
- (2021) Yu-Qian Sun et al. Frontiers in Oncology
- Re-Emergence of Minimal Residual Disease Detected by Flow Cytometry Predicts an Adverse Outcome in Pediatric Acute Lymphoblastic Leukemia
- (2021) Yu Wang et al. Frontiers in Oncology
- Pre‐transplantation cytoreduction does not benefit advanced myelodysplastic syndrome patients after myeloablative transplantation with grafts from family donors
- (2021) Yu‐Qian Sun et al. Cancer Communications
- The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
- (2021) Ya-Zhen Qin et al. Blood Cancer Journal
- G-CSF-Primed Peripheral Blood Stem Cell Haploidentical Transplantation Could Achieve Satisfactory Clinical Outcomes for Acute Leukemia Patients in the First Complete Remission: A Registered Study
- (2021) Yan-Ru Ma et al. Frontiers in Oncology
- Prognostic values of D816V KIT mutation and peri-transplant CBFB-MYH11 MRD monitoring on acute myeloid leukemia with CBFB-MYH11
- (2021) Byung-Sik Cho et al. BONE MARROW TRANSPLANTATION
- Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group
- (2021) Lan-Ping Xu et al. BONE MARROW TRANSPLANTATION
- Optimizing antithymocyte globulin dosing in haploidentical hematopoietic cell transplantation: long-term follow-up of a multicenter, randomized controlled trial
- (2021) Yu Wang et al. Science Bulletin
- Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes
- (2021) Sijian Yu et al. JAMA Network Open
- Detection of measurable residual disease may better predict outcomes than mutations based on next‐generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA
- (2020) Jing Wang et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comparable survival outcome between transplantation from haploidentical donor and matched related donor or unrelated donor for severe aplastic anemia patients aged 40 years and older: A retrospective multicenter cohort study
- (2020) Yuan‐Yuan Zhang et al. CLINICAL TRANSPLANTATION
- Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
- (2020) Abraham S. Kanate et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
- (2020) Anita D'Souza et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody
- (2020) Ying-Jun Chang et al. BONE MARROW TRANSPLANTATION
- Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT)
- (2020) Ghada ElGohary et al. BONE MARROW TRANSPLANTATION
- Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data
- (2020) Sijian Yu et al. Journal of Hematology & Oncology
- Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study
- (2020) Houli Zhao et al. Journal of Hematology & Oncology
- Comparison of haplo-SCT and chemotherapy for young adults with standard-risk Ph-negative acute lymphoblastic leukemia in CR1
- (2020) Meng Lv et al. Journal of Hematology & Oncology
- Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study
- (2020) Ying-Jun Chang et al. Journal of Hematology & Oncology
- Different Effects of Pre-transplantation Measurable Residual Disease on Outcomes According to Transplant Modality in Patients With Philadelphia Chromosome Positive ALL
- (2020) Si-Qi Li et al. Frontiers in Oncology
- Haploidentical‐ versus identical‐sibling transplant for high‐risk pediatric AML: A multi‐center study
- (2020) Feng-Mei Zheng et al. Cancer Communications
- Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee
- (2020) Ghada Algwaiz et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment
- (2020) Guan-hua Hu et al. BMC CANCER
- The loss or absence of minimal residual disease of
- (2020) Wenbing Duan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study
- (2020) Ying-Jun Chang et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia
- (2020) Limin Liu et al. LEUKEMIA
- Long‐term results of the NF‐08‐TM protocol in stem cell transplant for patients with thalassemia major: A multi‐center large‐sample study
- (2020) Yuelin He et al. AMERICAN JOURNAL OF HEMATOLOGY
- Unmanipulated haploidentical hematopoietic stem cell transplantation for children with myelodysplastic syndrome
- (2020) Pan Suo et al. PEDIATRIC TRANSPLANTATION
- Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
- (2020) Jiali Li et al. Frontiers in Oncology
- Minimal residual disease detected by multiparameter flow cytometry is complementary to genetics for risk stratification treatment in acute myeloid leukemia with biallelic CEBPA mutations
- (2019) Dao-Xing Deng et al. LEUKEMIA & LYMPHOMA
- Antithymocyte globulin improves GVHD-free and relapse-free survival in unrelated hematopoietic stem cell transplantation
- (2019) Yi Luo et al. BONE MARROW TRANSPLANTATION
- Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
- (2019) Rafael F. Duarte et al. BONE MARROW TRANSPLANTATION
- Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis
- (2019) Yan Huang et al. Cancer Management and Research
- G-CSF-Mobilized Blood and Bone Marrow Grafts as the Source of Stem Cells for HLA-Identical Sibling Transplantation in Patients with Thalassemia Major
- (2019) Qiaochuan Li et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Selection of Unrelated Donors and Cord Blood Units for Hematopoietic Cell Transplantation: Guidelines from NMDP/CIBMTR
- (2019) Jason Dehn et al. BLOOD
- Anti‐CD19 chimeric antigen receptor‐modified T‐cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B‐cell acute lymphoblastic leukemia: An open‐label pragmatic clinical trial
- (2019) Huiwen Jiang et al. AMERICAN JOURNAL OF HEMATOLOGY
- Conditioning Regimen of 5-Day Decitabine Administration for Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Myeloproliferative Neoplasms
- (2019) Yi-Geng Cao et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
- (2019) Ren Lin et al. BMC Medicine
- Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients
- (2019) Yu Wang et al. Journal of Hematology & Oncology
- Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
- (2019) Lan-Ping Xu et al. Journal of Hematology & Oncology
- Haploidentical hematopoietic cell transplantation for severe acquired aplastic anemia: a case-control study of post-transplant cyclophosphamide included regimen vs. anti-thymocyte globulin & colony-stimulating factor-based regimen
- (2019) Lanping Xu et al. Science China-Life Sciences
- Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF/ATG and posttransplant cyclophosphamide: results from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG)
- (2019) Feifei Tang et al. Science China-Life Sciences
- The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia
- (2019) Meng-Ge Gao et al. ANNALS OF HEMATOLOGY
- Hypomethylating agents for patients with myelodysplastic syndromes prior to hematopoietic stem cell transplantation: a systematic review and meta-analysis
- (2019) Yao Qin et al. ANNALS OF HEMATOLOGY
- Efficacy and Safety of CAR19/22 T-cell "Cocktail" Therapy in Patients with Refractory/ Relapsed B-Cell Malignancies
- (2019) Na Wang et al. BLOOD
- Impact of FLT3-ITD allele ratio and ITD length on therapeutic outcome in cytogenetically normal AML patients without NPM1 mutation
- (2019) Fang Chen et al. BONE MARROW TRANSPLANTATION
- Outcomes of haploidentical haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria
- (2019) Limin Liu et al. BONE MARROW TRANSPLANTATION
- Improved survival after offspring donor transplant compared with older aged‐matched siblings for older leukaemia patients
- (2019) Yu Wang et al. BRITISH JOURNAL OF HAEMATOLOGY
- Superior survival of unmanipulated haploidentical haematopoietic stem cell transplantation compared with intensive chemotherapy as post‐remission treatment for children with very high‐risk philadelphia chromosome negative B‐cell acute lymphoblastic leukaemia in first complete remission
- (2019) Yu‐juan Xue et al. BRITISH JOURNAL OF HAEMATOLOGY
- HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation
- (2019) Xin Jin et al. LEUKEMIA
- Post‐chimeric antigen receptor T‐cell therapy haematopoietic stem cell transplantation for 52 cases with refractory/relapsed B‐cell acute lymphoblastic leukaemia
- (2019) Yan Zhang et al. BRITISH JOURNAL OF HAEMATOLOGY
- Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort study
- (2019) Sijian Yu et al. LEUKEMIA
- Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia
- (2018) Yue Lu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
- (2018) Jing Wang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis
- (2018) Yao Chen et al. BONE MARROW TRANSPLANTATION
- The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology
- (2018) Lanping Xu et al. Journal of Hematology & Oncology
- Donor-derived CAR-T Cells Serve as a Reduced-intensity Conditioning Regimen for Haploidentical Stem Cell Transplantation in Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia
- (2018) Cheng Zhang et al. JOURNAL OF IMMUNOTHERAPY
- Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China
- (2018) Yunjing Zeng et al. Scientific Reports
- Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes
- (2018) Ling Wang et al. BONE MARROW TRANSPLANTATION
- The role of collateral related donors in haploidentical hematopoietic stem cell transplantation
- (2018) Xiao-Dong Mo et al. Science Bulletin
- Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era
- (2018) Yu-juan Xue et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study
- (2018) Jun Yang et al. BONE MARROW TRANSPLANTATION
- Myeloablative haploidentical transplantation is superior to chemotherapy for patients with intermediate-risk acute myelogenous leukemia in first complete remission
- (2018) Meng Lv et al. CLINICAL CANCER RESEARCH
- Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis
- (2017) Ying-Jun Chang et al. Journal of Hematology & Oncology
- Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant
- (2017) Lan-Ping Xu et al. Journal of Hematology & Oncology
- Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants
- (2017) Y Wang et al. LEUKEMIA
- Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2017) Bin Gu et al. LEUKEMIA RESEARCH
- Allogeneic Hematopoietic Stem Cell Transplantation in Thirty-Four Pediatric Cases of Mucopolysaccharidosis—A Ten-Year Report from the China Children Transplant Group
- (2016) Jianmin Wang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Unmanipulated haploidentical haematopoietic stem cell transplantation for children with severe aplastic anaemia
- (2016) Hua Zhu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study
- (2016) Lan-Ping Xu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study
- (2016) Y. Wang et al. CLINICAL CANCER RESEARCH
- Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia
- (2016) Xiao-Dong Mo et al. INTERNATIONAL JOURNAL OF CANCER
- How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
- (2016) Ying-Jun Chang et al. Journal of Hematology & Oncology
- Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia
- (2016) Bo Cai et al. Journal of Hematology & Oncology
- Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant
- (2016) Y Wang et al. LEUKEMIA
- Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
- (2015) Yu Wang et al. BLOOD
- Guidelines for the diagnosis and management of adult aplastic anaemia
- (2015) Sally B. Killick et al. BRITISH JOURNAL OF HAEMATOLOGY
- Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets
- (2015) Ying-Jun Chang et al. Journal of Hematology & Oncology
- Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China
- (2015) Li Gao et al. Journal of Hematology & Oncology
- T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT
- (2014) Y. Luo et al. BLOOD
- Who is the best donor for a related HLA haplotype-mismatched transplant?
- (2014) Y. Wang et al. BLOOD
- EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantation
- (2014) H-t Wang et al. BONE MARROW TRANSPLANTATION
- MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial
- (2013) H.-H. Zhu et al. BLOOD
- The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission
- (2012) X.-J. Huang et al. BLOOD
- Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research
- (2009) Sergio Giralt et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now